Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New screening system aims to catch hidden heart damage after surgery

NCT ID NCT05859620

Knowledge-focused Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a new screening system can help doctors find heart complications early in high-risk patients after noncardiac surgery. Researchers will track 900 patients to see how well the screening works in practice and what it costs. The goal is to gather information for a future larger trial, not to test a new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a standard screening system that catches heart problems early after surgery, potentially improving patient outcomes and reducing costs.
What could go wrong
This is an observational study, not testing a new treatment. It only measures feasibility and costs, so it won't directly prove that screening saves lives or prevents complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 900 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2021

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 40-85 years at increased cardiovascular risk undergoing inpatient, noncardiac, elective or emergent surgery with a planned postoperative stay of ≥2 nights

Ages

40 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Consecutive patients fulfilling the institutional criteria for inclusion into the routine PMI-screening * aged 40-85 years * at increased cardiovascular risk * undergoing inpatient, noncardiac, elective or emergent surgery * postoperative stay of ≥2 nights at the participating institution * orthopaedic, traumatology, vascular, spinal, thoracic, neurosurgical, and visceral surgery. Exclusion Criteria: * patients with cardiac surgery or interventions in the last 14 days * chronic renal failure under dialysis, renal transplant surgery * moderate-to-severe dementia * previous inclusion within 5 days * documented refusal to use of their data for research purposes or refusal of further use during follow-up * Patients declining consent for follow-up will be excluded from follow-up analyses.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction Myocardial injury Perioperative complication

Contacts and locations

Locations

  • Bürgerspital Solothurn

    Solothurn, 4500, Switzerland

  • Canton Hospital Olten

    Olten, Canton of Solothurn, 4600, Switzerland

  • Cantonal Hospital Lucerne

    Lucerne, Canton of Lucerne, 6000, Switzerland

  • University Hospital Geneva

    Geneva, Canton of Geneva, 1205, Switzerland

  • University Hospital Innsbruck

    Innsbruck, Tyrol, 6020, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.